Skip to content

Eucrates Biomedical Acquisition Corp.

Delisted

CIK 1822929fmd_10NPP39691NB1WJ1RNB7GSJKK0Finance, Insurance and Real Estate · Blank ChecksTemplate: Standard

Coverage: Jan 02, 2020 to Dec 31, 2022, 10 periods

Latest annual · FY2022

Millions
Operating income
(1)
Net income
2

Latest quarter · Q4 FY2022

Millions
Operating income
(0)
Net income
0
Open Financials

Eucrates Biomedical Acquisition Corp. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2022FY2021ChangeSource
Operating income-$698,578-$743,07110-K 2023-04-13 · proof
Net income$2.4 million$3.8 million-36.7%10-K 2023-04-13 · proof
Cash from operating activities-$630,291-$502,10810-K 2023-04-13 · proof
Total assets$12.5 million$105.1 million-88.1%10-K 2023-04-13 · proof
Total liabilities$3.9 million$5.8 million-31.9%10-K 2023-04-13 · proof
Cash and cash equivalents$18,865$49,156-61.6%10-K 2023-04-13 · proof
What was Eucrates Biomedical Acquisition Corp.'s operating income in fiscal 2022?
Eucrates Biomedical Acquisition Corp. reported operating income of -$698,578 for fiscal 2022 (the year ended Dec 31, 2022), against -$743,071 the year before. Source: the 10-K filed with the SEC on Apr 13, 2023. SEC
What was Eucrates Biomedical Acquisition Corp.'s net income in fiscal 2022?
Eucrates Biomedical Acquisition Corp. reported net income of $2.4 million for fiscal 2022 (the year ended Dec 31, 2022), against $3.8 million the year before (-36.7%). Source: the 10-K filed with the SEC on Apr 13, 2023. SEC
What was Eucrates Biomedical Acquisition Corp.'s cash from operating activities in fiscal 2022?
Eucrates Biomedical Acquisition Corp. reported cash from operating activities of -$630,291 for fiscal 2022 (the year ended Dec 31, 2022), against -$502,108 the year before. Source: the 10-K filed with the SEC on Apr 13, 2023. SEC
What are Eucrates Biomedical Acquisition Corp.'s total assets?
As of Dec 31, 2022, Eucrates Biomedical Acquisition Corp. reported total assets of $12.5 million, against $105.1 million a year earlier (-88.1%). Source: the 10-K filed with the SEC on Apr 13, 2023. SEC
What are Eucrates Biomedical Acquisition Corp.'s total liabilities?
As of Dec 31, 2022, Eucrates Biomedical Acquisition Corp. reported total liabilities of $3.9 million, against $5.8 million a year earlier (-31.9%). Source: the 10-K filed with the SEC on Apr 13, 2023. SEC
What are Eucrates Biomedical Acquisition Corp.'s cash and cash equivalents?
As of Dec 31, 2022, Eucrates Biomedical Acquisition Corp. reported cash and cash equivalents of $18,865, against $49,156 a year earlier (-61.6%). Source: the 10-K filed with the SEC on Apr 13, 2023. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1822929&period_type=annual&limit=5"

Information only, not investment advice.